Pridopidine

Pridopidine

Identifiers
IUPAC name 4-(3-methylsulfonylphenyl)-1-propylpiperidine
CAS Number	346688-38-8
PubChem CID	9795739
DrugBank	DB05371
ChemSpider	7971505
UNII	HD4TW8S2VK
KEGG	D09953
ChEMBL	ChEMBL596802
CompTox Dashboard (EPA)	DTXSID90188225
ECHA InfoCard	100.240.998
Chemical and physical data
Formula	C15H23NO2S
Molar mass	281.41 g·mol−1
3D model (JSmol)	Interactive image
SMILES CCCN1CCC(CC1)C2=CC(=CC=C2)S(=O)(=O)C
InChI InChI=1S/C15H23NO2S/c1-3-9-16-10-7-13(8-11-16)14-5-4-6-15(12-14)19(2,17)18/h4-6,12-13H,3,7-11H2,1-2H3 Key:YGKUEOZJFIXDGI-UHFFFAOYSA-N

Pridopidine (developmental code name PL-101) is an orally administrated small molecule investigational drug. Pridopidine is a selective and potent Sigma-1 Receptor agonist. It is being developed by Prilenia Therapeutics and is currently in late-stage clinical development for Huntington's disease (HD) and amyotrophic lateral sclerosis (ALS).